Tenon Medical closes $2.87 million warrant inducement, issues 858,269 new warrants
Tenon Medical said holders exercised 572,179 existing warrants at $5.02 per share, bringing gross proceeds of $2,872,338.58, and received new five-year warrants for 858,269 shares at the same price. The deal was announced September 11, 2026 and closed September 14, 2026, with the company stating it will use the proceeds for working capital and general corporate purposes. Shareholders may face dilution if the new warrants are exercised, and the company agreed to register the resale of the underlying shares.
Key points
- Existing warrants for 572,179 shares were exercised at $5.02 per share, with gross proceeds of $2,872,338.58, according to the filing.
- New Series B warrants cover up to 858,269 shares, equal to 150% of the shares issued on exercise, with a $5.02 exercise price and a five-year term.
- WallachBeth Capital LLC, the financial advisor, will receive a cash fee of 7% of gross proceeds plus legal expense reimbursement up to $65,000.
- Tenon must file a resale registration statement within 30 calendar days of September 11, 2026 and seek effectiveness within 60 days, or 90 days if the SEC conducts a full review.
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 16, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.